This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Washington SHB 1541 Signed Into Law

SEATTLE, May 8, 2013 /PRNewswire/ -- Washington Governor Jay Inslee Wednesday signed into law Substitute House Bill 1541 adding nasal spray medications to a list of medications able to be administered to school age children in Washington. The legislation allows emergent medication to be delivered immediately by a school nurse, or if a school nurse is not on school property administered by a designated trained representative.

"This is monumental for children with epilepsy in Washington who can now go to school knowing seizure cessation medication can be provided at the onset of a seizure," said Brent Herrmann, President/CEO of the Epilepsy Foundation Northwest.  "It took a frustrated mom of a child with epilepsy to bring the matter to the attention of the legislature to change law."

With the urging of Richland, WA mom, Heather Franklin, 8 th District Rep. Brad Klippert of Kennewick, WA introduced the bill in the Washington House of Representatives in January that passed in March by a bipartisan 97-0 margin. The Senate supported the bill with a 48-0 margin in April sending it to Governor Inslee for signature.

Mr. Herrmann went on to say, "We are thankful for the Governor's signature and bipartisan legislative support confirming what we've been saying for some time. No child should have their prescribed medication withheld in schools during life threatening situations. The need for increased seizure education and awareness continues with the signing of this law, especially with advances in health care and medication treatment options."

In a recent letter to the Washington State Senate, Dr. Edward Novotny, Head of Seattle Children's Hospital Epilepsy Program said, "Children in Washington deserve access to basic treatments while attending school that is equivalent to care provided at home by their families and caregivers. This includes treatment of a prolonged seizure or clusters of seizures that may be treated by administration of medication by a nasal spray. Families living with epilepsy deserve the same kind of treatment options that could minimize brain damage, improve their quality of life, reduce financial burden and most importantly save the life of their child."

Under the new law, those who deliver nasal sprays may be required to be trained and supervised by the school nurse or other healthcare providers and must submit a letter detailing their willingness to give the medications. They are also required to call 911 after giving a child the drug.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs